<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:41:24Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8459478" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8459478</identifier>
        <datestamp>2021-09-23</datestamp>
        <setSpec>bmcorhl</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Oral Health</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Oral Health</journal-id>
              <journal-title-group>
                <journal-title>BMC Oral Health</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1472-6831</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8459478</article-id>
              <article-id pub-id-type="pmcid">PMC8459478</article-id>
              <article-id pub-id-type="pmc-uid">8459478</article-id>
              <article-id pub-id-type="pmid">34556118</article-id>
              <article-id pub-id-type="publisher-id">1837</article-id>
              <article-id pub-id-type="doi">10.1186/s12903-021-01837-0</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Does low dose of etoricoxib play pre-emptive analgesic effect in third molar surgery? A randomized clinical trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Xie</surname>
                    <given-names>Long</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Sang</surname>
                    <given-names>Lei</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Li</surname>
                    <given-names>Zhi</given-names>
                  </name>
                  <address>
                    <email>zhili@whu.edu.cn</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution>The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, </institution><institution>Wuhan University, </institution></institution-wrap>Wuhan, China </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution>Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, </institution><institution>Wuhan University, </institution></institution-wrap>237 Luoyu Road, Wuhan, 430079 China </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.488140.1</institution-id><institution>Department of Stomatology, </institution><institution>Suzhou Vocational Health College, </institution></institution-wrap>Suzhou, China </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>23</day>
                <month>9</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>23</day>
                <month>9</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>21</volume>
              <elocation-id>462</elocation-id>
              <history>
                <date date-type="received">
                  <day>22</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>17</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">How to prevent pain after the extraction of impacted teeth is a serious challenge for all patients. The purpose of this clinical trial was to investigate whether pre-emptive low dose of etoricoxib can reduce postoperative pain in patients undergoing third molars surgery.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Patients were randomised to receive etoricoxib 60 mg or placebo 30 min before surgery. Post-operative pain was recorded using a visual analogue scale during 24 h within the post-operative period. The total dose of ibuprofen rescue intake was recorded. Kaplan–Meier curves and log-rank analyses were used to evaluate the proportion of patients without rescue analgesic.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Scores for the post-operative pain in the etoricoxib group were significantly lower than those in the placebo group during first 12 h (<italic>p</italic> &lt; 0.05). The number of patients without analgesic rescue medication was significantly lower in the etoricoxib group than in the placebo group. The average amount of rescue medication in the etoricoxib group (0.4 ± 0.9 dose) was lower than that in the placebo group (1.1 ± 0.9 doses, <italic>p</italic> = 0.004). Etoricoxib resulted in the long-term survival of patients without rescue analgesic (<italic>p</italic> &lt; 0.001).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">This study revealed that etoricoxib has a substantial pre-emptive analgesic effect, resulting in the reduced use of analgesics after third molar removal.</p>
                  <p id="Par5"><italic>Trial registration</italic>: Registered on ChiCTR1900024503. Date of Registration: 13/07/2019.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s12903-021-01837-0.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Pre-emptive analgesia</kwd>
                <kwd>Etoricoxib</kwd>
                <kwd>Third molar</kwd>
                <kwd>Extraction</kwd>
                <kwd>Post-operative pain</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par13">Acute pain caused by mandibular third molar removal is widely used to evaluate the efficacy of analgesics. Treatment of moderate or severe pain is usually given after the operation to reduce the dispersion of pain intensity measures by only including patients who need analgesics [<xref ref-type="bibr" rid="CR1">1</xref>]. Agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen and opioids, are effective in treating acute pain [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
              <p id="Par14">NSAIDs contain two cyclooxygenase isoforms, namely, cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) [<xref ref-type="bibr" rid="CR3">3</xref>]. COX-1 is constitutively expressed in tissues and promotes the synthesis of prostaglandin (PG). The gastric and renal side effects of NSAIDs may be due to their indirect influence on PGE2, which has a cytoprotective effect in the gastrointestinal system, as well as on PGE2 and PGI2, which regulate renal blood flow [<xref ref-type="bibr" rid="CR4">4</xref>]. COX-2 is also located in certain healthy tissues, but this isoform is especially induced by inflammatory stimulus or mitogen in some tissues. The expression of COX-2 may be related to the synthesis of PG, which induces responses to pathological processes, such as pain, fever and inflammation [<xref ref-type="bibr" rid="CR5">5</xref>]. Although nonselective NSAIDs are first-line analgesics, their additional inhibition of COX-1 increases the hazard of gastrointestinal toxicity and thus limits their administration [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
              <p id="Par15">Etoricoxib, as the COX-2 selective class of NSAIDs, can provide patients with effective painkillers who do not benefit adequately from first-line therapies [<xref ref-type="bibr" rid="CR7">7</xref>]. As the second generation of the selective class of NSAIDs, in various cells and whole blood tests, etoricoxib is more than 100 times selective for COX-2 than for COX-1 and is obviously less active against COX-1 than other selective COX-2 inhibitors [<xref ref-type="bibr" rid="CR8">8</xref>]. This drug is also effective in relieving pain during dental procedures, total abdominal hysterectomy, periodontal surgery and therapeutic knee arthroscopy [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. This type of NSAID is a safe and effective drug that controls postoperative pain with minimal side effects.</p>
              <p id="Par16">The pre-emptive analgesic of large doses of etoricoxib (120 mg) has been demonstrated to reduce pain after tooth extraction surgery [<xref ref-type="bibr" rid="CR13">13</xref>]. At present, few studies were conducted on the use of low-dose etoricoxib (60 mg) after the operation of impacted teeth, and the results cannot provide a basis for clinical practice [<xref ref-type="bibr" rid="CR1">1</xref>]. Our clinical trial was performed to evaluate the efficacy of a low dose of etoricoxib (60 mg) on alleviating pain after third molar surgery.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study design and sample</title>
                <p id="Par17">This study was designed as a randomized, parallel, double-blinded and placebo-controlled clinical trial from August 2019 to July 2020. Healthy patients scheduled to undergo surgical removal of an impacted horizontal mandibular third molar (Winter classification) were eligible for participation. Patients were included if they were older than 18 years old, had horizontal impacted teeth, did not take analgesics or anti-inflammatory drugs a week prior to the study. Patients were excluded if they took NSAIDs and COX-2 inhibitors; were pregnant or nursing; had other serious diseases, such as liver, kidney and cardiovascular diseases; had ulcers or bleeding in the digestive tract; had the history of GI bleeding and gastritis; had inability to express subjective discomfort symptoms; and suffered from dental caries or apical periodontitis with the adjacent teeth. The Patients were given standardised participant information sheets and signed written informed consent for their participation.</p>
                <p id="Par18">All patients were informed about the study protocol and possible risks prior to any procedure. The patients were randomly divided into etoricoxib and placebo groups by Excel software. The etoricoxib group orally receive etoricoxib tablet 60 mg (Merck&amp;Co., Inc) or placebo group (tablet, without active drug) 30 min before surgery. The operator and the patients were blinded to the type of drugs administered. To prevent postoperative infection, 0.5 g dose of amoxicillin and 0.4 g dose of metronidazole tablets were taken orally, 3 times a day, for 5 days, and 1.0 g dose of azithromycin was given once a day for 5 days if allergic to amoxicillin.</p>
              </sec>
              <sec id="Sec4">
                <title>Randomisation and blinding</title>
                <p id="Par19">The patients were divided into two groups (placebo and 60 mg of etoricoxib) by Excel software to achieve randomisation. Allocation concealment was maintained using a sealed opaque envelope. The research assistant prepared the study drugs for the clinic nurses according to the randomisation list. A dedicated nurse, as non-treatment group members, gave the study drugs sealed in a similar package to the patients 30 min before the surgery.</p>
              </sec>
              <sec id="Sec5">
                <title>Sample size calculation</title>
                <p id="Par20">Based on the mean pain scores of previous study [<xref ref-type="bibr" rid="CR14">14</xref>] (etoricoxib 1.9 ± 1.5 and placebo 3.6 ± 1.9), a minimum sample size of twenty-eight patients per group were required to conduct this clinical trial and statistically reject the null hypothesis with 95% power. For this sample calculation, the type 1 error associated with the test was 0.05; χ2 test without correction was used to evaluate the null hypothesis. The sample unit used in the present study was the third molar.</p>
              </sec>
              <sec id="Sec6">
                <title>Interventions</title>
                <p id="Par21">All operations were performed by the same attending doctor to minimise differences between operators. The same local anaesthesia technique was performed on the patients. The anaesthesia of inferior alveolar, lingual and buccal nerves block was performed with 2% lidocaine. For local infiltration anaesthesia, 4% atecaine and 1:100,000 epinephrine (Septanest, Septodont, France) were used to reduce intraoperative bleeding. Both groups received the same surgical procedure to reduce surgery-related bias. The buccal mucoperiosteal flap was elevated, the bone was removed and the tooth was sectioned. After the tooth was extracted, the alveolar tissue was scraped and rinsed with sterile saline solution. The wound was sutured with a 4–0 silk, and the suture was removed 1 week after the surgery. The operative time was calculated from flap dissection and suture after tooth extraction.</p>
              </sec>
              <sec id="Sec7">
                <title>Pain assessment</title>
                <p id="Par22">An 11-point (0 to 10) visual analogue score (VAS) was used to evaluate pain (0, no pain; 1–3, mild pain; 4–6, moderate pain; 7–9, severe pain; and 10, miserable pain.</p>
                <p id="Par23">). Postoperative pain was assessed and scored at 2, 4, 6, 8, 12 and 24 h after the operation. Ibuprofen (300 mg) was prescribed as the emergency analgesic only in the case of VAS &gt; 3. The patients were asked to record their total consumption of ibuprofen (amount of tablets) within the first 24 h (at 2, 4, 6, 8, 12 and 24 h) and the time of the first analgesic rescue medication after the procedure was completed.</p>
              </sec>
              <sec id="Sec8">
                <title>Statistical analysis</title>
                <p id="Par24">Data were analysed with SPSS software (SPSS, Inc., USA). Independent t-test and Chi-square were used to determine significant difference between the two groups. The parametric outcomes were expressed as mean ± standard deviation (SD). The survival curves were estimated by the Kaplan–Meier method, and log-rank test was applied to compare differences between curves. <italic>p</italic> value less than 0.05 was considered statistically significant.</p>
              </sec>
            </sec>
            <sec id="Sec9">
              <title>Results</title>
              <sec id="Sec10">
                <title>Sample characterisation</title>
                <p id="Par25">Eighty patients were considered eligible (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Twenty-four individuals were excluded because they did not meet the study criteria. Finally, 56 patients (male and female aged between 18 and 45 years) were selected for the clinical trial and randomly divided into etoricoxib and control groups. None of the drugs used had reported side effects. No differences were detected in terms of age, gender, BMI and duration of the operation between the two groups (Table <xref rid="Tab1" ref-type="table">1</xref>). Table <xref rid="Tab2" ref-type="table">2</xref> shows the level of impaction (Pell–Gregory classification) for the patients in each of the study groups. There was no significant difference between the two groups for any parameter.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flowchart of participants recruitment according to the CONSORT protocol</p></caption><graphic xlink:href="12903_2021_1837_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Placebo</th><th align="left">Etoricoxib</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Age(years)</td><td align="left">28.1 ± 5.0</td><td align="left">29.4 ± 5.0</td><td align="left">.368<sup>a</sup></td></tr><tr><td align="left">BMI(kg/m<sup>2</sup>)</td><td align="left">21.4 ± 3.0</td><td align="left">22.6 ± 3.2</td><td align="left">.174<sup>a</sup></td></tr><tr><td align="left">Gender (M/F)</td><td align="left">10/18</td><td align="left">13/15</td><td align="left">.587<sup>b</sup></td></tr><tr><td align="left">Duration of the operation (minutes)</td><td align="left">14.0 ± 4.8</td><td align="left">15.8 ± 5.3</td><td align="left">.191<sup>a</sup></td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean (standard deviation) or number</p><p>BMI, body mass index</p><p><sup>a</sup>By t test</p><p><sup>b</sup>By χ<sup>2</sup> test</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Pell and Gregory classification</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">2B</th><th align="left">2C</th><th align="left">χ<sup>2</sup></th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Placebo (n = 29)</td><td align="left">18</td><td align="left">11</td><td align="left" rowspan="2">0.284</td><td align="left" rowspan="2">0.790</td></tr><tr><td align="left">Etoricoxib (n = 29)</td><td align="left">16</td><td align="left">13</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec11">
                <title>Pain (VAS) analysis</title>
                <p id="Par26">Table <xref rid="Tab3" ref-type="table">3</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref> show the mean VAS pain score at each postoperative time. The mean VAS score in the etoricoxib group was significantly lower than that in the placebo group in the first 12 h during the follow-up period after the surgery.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Average pain measurements in study groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Timing of VAS Score, h</th><th align="left">Placebo</th><th align="left">Etoricoxib</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">2</td><td char="." align="char">2.9 ± 2.8</td><td char="." align="char">1.1 ± 1.4</td><td align="left">.004**</td></tr><tr><td align="left">4</td><td char="." align="char">4.5 ± 2.5</td><td char="." align="char">2.1 ± 1.6</td><td align="left"><italic>p</italic> &lt; .001***</td></tr><tr><td align="left">6</td><td char="." align="char">3.8 ± 2.3</td><td char="." align="char">1.8 ± 1.4</td><td align="left"><italic>p</italic> &lt; .001***</td></tr><tr><td align="left">8</td><td char="." align="char">3.1 ± 2.5</td><td char="." align="char">1.5 ± 1.5</td><td align="left">.006**</td></tr><tr><td align="left">12</td><td char="." align="char">2.3 ± 2.2</td><td char="." align="char">1.1 ± 1.5</td><td align="left">.027*</td></tr><tr><td align="left">24</td><td char="." align="char">1.5 ± 1.5</td><td char="." align="char">0.9 ± 1.3</td><td align="left">.112</td></tr></tbody></table><table-wrap-foot><p>Values are expressed mean ± standard deviation</p><p>VAS, visual analog pain scale</p><p>Values are expressed mean ± standard deviation or number</p><p><sup>*</sup><italic>p</italic> &lt; 0.05 t-test between groups</p><p><sup>**</sup><italic>p</italic> &lt; 0.01 t-test between groups</p><p><sup>***</sup><italic>p</italic> &lt; 0.001 t-test between groups</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Pain scores at 2, 4, 6, 8, 12 and 24 h after surgery as measured on visual analog scale (VAS)</p></caption><graphic xlink:href="12903_2021_1837_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec12">
                <title>Rescue analgesic intake dose</title>
                <p id="Par27">Table <xref rid="Tab4" ref-type="table">4</xref> shows the average consumption of rescue analgesic during the 24 h period. Patients in the etoricoxib group required less rescue analgesic compared with those in the placebo group.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison of the average dosage and number of patients during 24-h rescue analgesic intake among groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Placebo<break/>(n = 28)</th><th align="left">Etoricoxib<break/>(n = 28)</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Number of patients who consumed the first rescue analgesic medication during the period of evaluation (24 h)</td><td align="left">21 (75%)</td><td align="left">8(28.6%)</td><td align="left">.001<sup>b</sup></td></tr><tr><td align="left">Number (%) of patients requiring no rescue analgesic medication during the period of evaluation (24 h)</td><td align="left">7(25%)</td><td align="left">20(71.4%)</td><td align="left">.001<sup>b</sup></td></tr><tr><td align="left">Total analgesic consumption for postoperative 24 h (tablets) (mean ± SD)</td><td align="left">1.1 ± 0.9</td><td align="left">0.4 ± 0.9</td><td align="left">.004<sup>a</sup></td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean (standard deviation) or number</p><p><sup>a</sup>By t test</p><p><sup>b</sup>By χ<sup>2</sup> test</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec13">
                <title>Interval to the first intake of ibuprofen</title>
                <p id="Par28">The Kaplan–Meier curve in Fig. <xref rid="Fig3" ref-type="fig">3</xref> shows the data of patients who took emergency analgesics within 24 h after the surgery. In the etoricoxib group, 71.4% of the patients did not take any painkillers after the surgery, which was 46.4% more than that in the placebo group (<italic>P</italic> = 0.001). The overall survival time (the interval to the first intake of ibuprofen) in the etoricoxib group was longer than that in the placebo group (<italic>P</italic> &lt; 0.001).<fig id="Fig3"><label>Fig. 3</label><caption><p>Kaplan–Meier curve for overall survival stratified by etoricoxib group and placebo group use (Log rank test)</p></caption><graphic xlink:href="12903_2021_1837_Fig3_HTML" id="MO3"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec14">
              <title>Discussion</title>
              <p id="Par29">This study revealed that pre-emptive oral administration of etoricoxib (60 mg) is an effective pain management strategy compared to placebo after third molar surgery. Etoricoxib (60 mg) significantly reduced the pain scores during the first 12 postoperative hours, resulting in longer overall survival time (the interval to the first intake of ibuprofen) and reduced need of rescued analgesic consumption within 24 h after the surgery.</p>
              <p id="Par30">About 60% of the patients suffered moderate pain, and 40% had severe pain, which had higher requirements for analgesia [<xref ref-type="bibr" rid="CR15">15</xref>]. Inadequate postoperative pain management resulted in a significant deterioration in the quality of life of the patients after third molar removal [<xref ref-type="bibr" rid="CR16">16</xref>]. Therefore, pain management after third molar removal has received extensive attention from surgeons and patients. In 2010, the Italian Society of Odontostomatological Surgery made the recommendation that pre-emptive analgesia is expected to be the most effective method for controlling postoperative pain [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
              <p id="Par31">Pre-emptive analgesia is a treatment initiated before the operation to prevent central sensitisation due to incision injury and other inflammatory reactions [<xref ref-type="bibr" rid="CR18">18</xref>]. Pre-emptive analgesia has been demonstrated to be safe and can decrease pain in the early postoperative period [<xref ref-type="bibr" rid="CR19">19</xref>]. This method has achieved good analgesic effects in several kinds of surgical operations. Pre-emptive analgesia of etoricoxib can reduce acute postoperative pain in patients who underwent orthopaedics surgery, laparoscopic cholecystectomy and panphotocoagulation [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. Albuquerque et al.[<xref ref-type="bibr" rid="CR14">14</xref>]. found that pre-emptive analgesia of etoricoxib (120 mg) can lead to reduce pain, trismus and oedema after third molar surgery.</p>
              <p id="Par32">A low dose of etoricoxib (60 mg) showed significant analgesic effect and minimal side effects compared to placebo. In a previous study, 500 patients with osteoarthritis (OA) were administered with 60 mg of etoricoxib once a day for 4 weeks without prior medication washout. Disability and pain interference in daily activities were significantly improved [<xref ref-type="bibr" rid="CR23">23</xref>]. In addition, the pain and disability scores measured by the Western Ontario and McMaster’s University OA index (WOMAC) in 19 extremely elderly men with OA (mean age, 85.9 years; age range, 79–96 years) were lower after treatment with 60 mg of etoricoxib once daily for 4 weeks; no adverse events were also reported [<xref ref-type="bibr" rid="CR24">24</xref>]. A double-blind and placebo-controlled study conducted a two-part dose-ranging clinical trial of etoricoxib (5–90 mg/day) starting at 14-week; during which, 60 mg of etoricoxib was found to have the best analgesic effect according to the WOMAC pain scale [<xref ref-type="bibr" rid="CR25">25</xref>]. Another clinical trial during the 46-week active-comparator controlled period, drug-related laboratory adverse experience, such as increase in alanine aminotransferase and aspartate aminotransferase, were reported for 2.0%, 0.0%, 4.1% and 11.8% in the groups administered with 30, 60 and 90 mg of etoricoxib and 150 mg of diclofenac, respectively [<xref ref-type="bibr" rid="CR26">26</xref>]. These studies indicated that a low dose of etoricoxib (60 mg) is safer than other doses.</p>
              <p id="Par33">In our study, a low dose of etoricoxib (60 mg) was more effective than placebo in preventing pain at first 12 h post-surgery. Gupta et al. discovered that a low dose of etoricoxib (60 mg) was highly effective in controlling pain during fixed orthodontic appliance therapy [<xref ref-type="bibr" rid="CR27">27</xref>]. In an acute pain model, postoperative analgesia of low dose of etoricoxib (60 mg) can reduce pain [<xref ref-type="bibr" rid="CR1">1</xref>]. Our research is similar to the above-mentioned study. However, according to Costa et al., pre-emptive 120 mg etoricoxib single dose provided significant analgesia compared to placebo in the first 48 h after surgery (compared to 12 h in present study), with no side effects [<xref ref-type="bibr" rid="CR13">13</xref>]. Although pre-emptive treatment with 120 mg etoricoxib had a longer-lasting analgesic effect compared to 60 mg etoricoxib, patients in Costa and this study experienced mild pain 24 h after surgery. To reduce mild pain, increasing the dose of etoricoxib may increase the risk of adverse reactions [<xref ref-type="bibr" rid="CR26">26</xref>]. Furthermore, in Costa's trial, the sample size was only 18 patients. If the sample size was increased, the odds of adverse reactions among patients might be increased. In this study, a pre-emptive of low dose of etoricoxib was enough to induce good analgesia with no side effects.</p>
              <p id="Par34">It should be noted that at the most pain intensity, the mean VAS measurements of treatment and placebo groups were 2.1 and 4.5 in this study. Maximum pain in this study was moderate in the placebo group. This may be related to the experience and skill of the surgeon. It is also clearly aware that the analgesic effect of low dose of etoricoxib should be specified to the mild/moderate surgery and should not be generalized for all cases at present.</p>
              <p id="Par35">PGE2 was highly expressed in the peripheral tissue and central nervous system during and after the surgery; upregulated of PGE2 was associated with increased pain scores on the VAS scale [<xref ref-type="bibr" rid="CR28">28</xref>]. Etoricoxib reached the cerebrospinal fluid (CSF) and the surgical site in an effective concentration and reduced the production of PGE2 at the presumed site of action [<xref ref-type="bibr" rid="CR29">29</xref>]. This process resulted in complete blockade of PGE2 production in the surgical wound and CSF. This phenomenon can lead to pain relief and reduce demands for post-operative analgesics.</p>
              <p id="Par36">The total analgesic consumption at 24 h post-operation (tablets, mean ± SD) in the etoricoxib group (0.4 ± 0.9) was less than that (1.1 ± 0.9) in the placebo group. The statistical difference between the two groups could be attributed to the analgesia, namely, etoricoxib, applied in this study. Through clinical trials, Malmstrom et al. found that patients with moderate or severe pain after removal of two or more third molars who took 120 mg of etoricoxib had reduced demand for rescue medication [<xref ref-type="bibr" rid="CR30">30</xref>]. Steffens et al.[<xref ref-type="bibr" rid="CR11">11</xref>]. proposed that the pre-emptive use of 120 mg of etoricoxib can relieve the post-operative pain after open-flap debridement surgery and reduce the total amount of rescue medication needed. Lower TNF-a concentration can lead to less rescue medication as a result of pre-emptive administration of 120 mg of etoricoxib after third molar removal compared with that in the placebo group [<xref ref-type="bibr" rid="CR14">14</xref>]. In the present research, pre-emptive analgesia of low dose of etoricoxib (60 mg) can reduce the need for emergency analgesics. This clinical trial showed longer interval between taking emergency analgesics in the etoricoxib group than in the placebo group. More patients in the control group (75.0% patients) used emergency analgesics than in the etoricoxib group (28.6% patients). Malmstrom and his colleagues discovered that during the 24 h of the study period, 52.0% of patients in the etoricoxib group (60 mg) and 81.6% in the placebo group used rescue medication [<xref ref-type="bibr" rid="CR1">1</xref>]. Compared with Malmstrom’s study, the present study showed that less patients took emergency analgesics because of removal of one third molars and the pre-emptive administration of etoricoxib. The interval between the first use of emergency analgesics was 12.1 h (etoricoxib 60 mg group) and 2.1 h (placebo group) [<xref ref-type="bibr" rid="CR1">1</xref>]. These data are consistent with our finding that patients in the etoricoxib group had not a degree of pain who necessitate intervention by analgesics compared with those in the placebo group. The long-term analgesic effect could be related to the elimination half-life of etoricoxib in plasma for 25–30 h [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
            </sec>
            <sec id="Sec15">
              <title>Limitation</title>
              <p id="Par37">This was a preliminary study with indispensable limitations. On the one hand, this study lacked a positive control group. This study found that low dose of etoricoxib was helpful to reduce postoperative pain after tooth extraction, but NSAID analgesics could also achieve this effect. Secondly, the postoperative follow-up time was only 24 h, and the pain assessment after 24 h was not observed. In the future study, we will extend the follow-up time and focus on the effect of etoricoxib compared with other NSAID drugs on postoperative pain after tooth extraction.</p>
            </sec>
            <sec id="Sec16">
              <title>Conclusions</title>
              <p id="Par38">This study revealed that a low dose of etoricoxib has pre-emptive analgesic effect, resulting in the reduced use of analgesics after third molar removal.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec17">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12903_2021_1837_MOESM1_ESM.docx">
                      <caption>
                        <p><bold>Additional file 1.</bold> Trail protocol.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>VAS</term>
                  <def>
                    <p id="Par6">Visual analog scale</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NSAIDs</term>
                  <def>
                    <p id="Par7">Nonsteroidal anti-inflammatory drugs</p>
                  </def>
                </def-item>
                <def-item>
                  <term>COX-1</term>
                  <def>
                    <p id="Par8">Cyclooxygenase-1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SD</term>
                  <def>
                    <p id="Par9">Standard deviation</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OA</term>
                  <def>
                    <p id="Par10">Osteoarthritis</p>
                  </def>
                </def-item>
                <def-item>
                  <term>WOMAC</term>
                  <def>
                    <p id="Par11">The Western Ontario and McMaster’s University OA index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PG</term>
                  <def>
                    <p id="Par12">Prostaglandin</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>Long Xie and Lei Sang contributed equally to this work and are considered as joint first authors</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>Not applicable.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors' contributions</title>
              <p>LX and LS Contributed to the design of the study, data analysis, results interpretation and in writing the manuscript. ZL Participated in planning of the research, literature search and critically reviewing the manuscript. LX Participated in study design, clinical work, analyzing data, results interpretation and in writing the manuscript. ZL Contributed to planning the clinical study and critically reviewing and editing the manuscript. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This research received no external funding.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par39">The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of School and Hospital of Stomatology, Wuhan University (approval number 2019-B11). Each parent signed an informed consent in the study.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par40">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par41">The authors declare no conflict of interest.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malmstrom</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Sapre</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Couglin</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Agrawal</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Mazenko</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Fricke</surname>
                      <given-names>JR</given-names>
                      <suffix>Jr</suffix>
                    </name>
                  </person-group>
                  <article-title>Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study</article-title>
                  <source>Clin Ther</source>
                  <year>2004</year>
                  <volume>26</volume>
                  <fpage>667</fpage>
                  <lpage>679</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0149-2918(04)90067-7</pub-id>
                  <pub-id pub-id-type="pmid">15220011</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mehrabi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Roser</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Therapeutic agents in perioperative third molar surgical procedures</article-title>
                  <source>Oral Maxillofac Surg Clin North Am</source>
                  <year>2007</year>
                  <volume>19</volume>
                  <fpage>69</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.coms.2006.11.010</pub-id>
                  <pub-id pub-id-type="pmid">18088865</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Seibert</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Leahy</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hauser</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Masferrer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Isakson</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Distribution of COX-1 and COX-2 in normal and inflamed tissues</article-title>
                  <source>Adv Exp Med Biol</source>
                  <year>1997</year>
                  <volume>400A</volume>
                  <fpage>167</fpage>
                  <lpage>170</lpage>
                  <pub-id pub-id-type="doi">10.1007/978-1-4615-5325-0_24</pub-id>
                  <pub-id pub-id-type="pmid">9547553</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Süleyman</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Demircan</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Karagöz</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Anti-inflammatory and side effects of cyclooxygenase inhibitors</article-title>
                  <source>Pharmacol Rep</source>
                  <year>2007</year>
                  <volume>59</volume>
                  <fpage>247</fpage>
                  <lpage>258</lpage>
                  <?supplied-pmid 17652824?>
                  <pub-id pub-id-type="pmid">17652824</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meade</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>WL</given-names>
                    </name>
                    <name>
                      <surname>DeWitt</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs</article-title>
                  <source>J Biol Chem</source>
                  <year>1993</year>
                  <volume>268</volume>
                  <fpage>6610</fpage>
                  <lpage>6614</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0021-9258(18)53294-4</pub-id>
                  <pub-id pub-id-type="pmid">8454631</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wolfe</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Lichtenstein</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs</article-title>
                  <source>N Engl J Med</source>
                  <year>1999</year>
                  <volume>340</volume>
                  <fpage>1888</fpage>
                  <lpage>1899</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM199906173402407</pub-id>
                  <pub-id pub-id-type="pmid">10369853</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brown</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Daniels</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Bandy</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Ko</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Gammaitoni</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Boice</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Losada</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Peloso</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain model</article-title>
                  <source>Clin J Pain</source>
                  <year>2013</year>
                  <volume>29</volume>
                  <fpage>492</fpage>
                  <lpage>498</lpage>
                  <pub-id pub-id-type="doi">10.1097/AJP.0b013e318260c144</pub-id>
                  <pub-id pub-id-type="pmid">23247002</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Riendeau</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Percival</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Brideau</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Charleson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dubé</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ethier</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Falgueyret</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Friesen</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Gordon</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Greig</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Guay</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Mancini</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ouellet</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Boyce</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Visco</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Girard</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Prasit</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Zamboni</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rodger</surname>
                      <given-names>IW</given-names>
                    </name>
                    <name>
                      <surname>Gresser</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ford-Hutchinson</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>CC</given-names>
                    </name>
                  </person-group>
                  <article-title>Etoricoxib (MK-0663): preclinical profile and comparison with otheragents that selectively inhibit cyclooxygenase-2</article-title>
                  <source>J Pharmacol Exp Ther</source>
                  <year>2001</year>
                  <volume>296</volume>
                  <fpage>558</fpage>
                  <lpage>566</lpage>
                  <?supplied-pmid 11160644?>
                  <pub-id pub-id-type="pmid">11160644</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daniels</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Bandy</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Christensen</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Boice</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Losada</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Peloso</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model</article-title>
                  <source>Clin J Pain</source>
                  <year>2011</year>
                  <volume>27</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1097/AJP.0b013e3181ed0639</pub-id>
                  <pub-id pub-id-type="pmid">21188849</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Viscusi</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Frenkl</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Hartrick</surname>
                      <given-names>CT</given-names>
                    </name>
                    <name>
                      <surname>Rawal</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Kehlet</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Papanicolaou</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Gammaitoni</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ko</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Peloso</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <article-title>Perioperative use of etoricoxib reduces pain and opioid side-effects aftertotal abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study</article-title>
                  <source>Curr Med Res Opin</source>
                  <year>2011</year>
                  <volume>28</volume>
                  <fpage>1323</fpage>
                  <lpage>1335</lpage>
                  <pub-id pub-id-type="doi">10.1185/03007995.2012.707121</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steffens</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Sartori</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Pilatti</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <article-title>Preemptive dexamethasone and etoricoxib for pain and discomfort prevention after periodontal surgery: a double-masked, crossover, controlled clinical trial</article-title>
                  <source>J Periodontol</source>
                  <year>2010</year>
                  <volume>81</volume>
                  <fpage>1153</fpage>
                  <lpage>1160</lpage>
                  <pub-id pub-id-type="doi">10.1902/jop.2010.100059</pub-id>
                  <pub-id pub-id-type="pmid">20367520</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lierz</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Losch</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Felleiter</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of a single preoperative dose of etoricoxib for postoperativepain relief in therapeutic knee arthroscopy: a randomized trial</article-title>
                  <source>Acta Orthop</source>
                  <year>2012</year>
                  <volume>83</volume>
                  <fpage>642</fpage>
                  <lpage>647</lpage>
                  <pub-id pub-id-type="doi">10.3109/17453674.2012.747053</pub-id>
                  <pub-id pub-id-type="pmid">23140090</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Costa</surname>
                      <given-names>FW</given-names>
                    </name>
                    <name>
                      <surname>Soares</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Esses</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Silva</surname>
                      <given-names>PG</given-names>
                    </name>
                    <name>
                      <surname>Bezerra</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Scarparo</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Ribeiro</surname>
                      <given-names>TR</given-names>
                    </name>
                    <name>
                      <surname>Fonteles</surname>
                      <given-names>CS</given-names>
                    </name>
                  </person-group>
                  <article-title>A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2015</year>
                  <volume>44</volume>
                  <fpage>1166</fpage>
                  <lpage>1174</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2015.06.012</pub-id>
                  <pub-id pub-id-type="pmid">26144571</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Albuquerque</surname>
                      <given-names>AFM</given-names>
                    </name>
                    <name>
                      <surname>Fonteles</surname>
                      <given-names>CSR</given-names>
                    </name>
                    <name>
                      <surname>do Val</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Chaves</surname>
                      <given-names>HV</given-names>
                    </name>
                    <name>
                      <surname>Bezerra</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Pereira</surname>
                      <given-names>KMA</given-names>
                    </name>
                    <name>
                      <surname>de Barros Silva</surname>
                      <given-names>PG</given-names>
                    </name>
                    <name>
                      <surname>de Lima</surname>
                      <given-names>BB</given-names>
                    </name>
                    <name>
                      <surname>Soares</surname>
                      <given-names>ECS</given-names>
                    </name>
                    <name>
                      <surname>Ribeiro</surname>
                      <given-names>TR</given-names>
                    </name>
                    <name>
                      <surname>Costa</surname>
                      <given-names>FWG</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of pre-emptive analgesia on clinical parameters and tissue levels of TNF-α and IL-1β in third molar surgery: a triple-blind, randomized, placebo-controlled study</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2017</year>
                  <volume>46</volume>
                  <fpage>1615</fpage>
                  <lpage>1625</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijom.2017.05.007</pub-id>
                  <pub-id pub-id-type="pmid">28610818</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Averbuch</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Katzper</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Severity of baseline pain and degree of analgesia in the third molar post-extraction dental pain model</article-title>
                  <source>Anesth Analg</source>
                  <year>2003</year>
                  <volume>97</volume>
                  <fpage>163</fpage>
                  <lpage>167</lpage>
                  <pub-id pub-id-type="doi">10.1213/01.ANE.0000063827.97392.5E</pub-id>
                  <pub-id pub-id-type="pmid">12818960</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duarte-Rodrigues</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Miranda</surname>
                      <given-names>EFP</given-names>
                    </name>
                    <name>
                      <surname>Souza</surname>
                      <given-names>TO</given-names>
                    </name>
                    <name>
                      <surname>de Paiva</surname>
                      <given-names>HN</given-names>
                    </name>
                    <name>
                      <surname>Falci</surname>
                      <given-names>SGM</given-names>
                    </name>
                    <name>
                      <surname>Galvão</surname>
                      <given-names>EL</given-names>
                    </name>
                  </person-group>
                  <article-title>Third molar removal and its impact on quality of life: systematic review and meta-analysis</article-title>
                  <source>Qual Life Res</source>
                  <year>2018</year>
                  <volume>27</volume>
                  <fpage>2477</fpage>
                  <lpage>2489</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11136-018-1889-1</pub-id>
                  <pub-id pub-id-type="pmid">29797177</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Annibali</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>De Biase</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pippi</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Sfasciotti</surname>
                      <given-names>GL</given-names>
                    </name>
                    <collab>Italian Society of Odontostomatological Surgery</collab>
                  </person-group>
                  <article-title>A consensus conference on management of the lower third molar Italian Society of Odontostomatological Surgery</article-title>
                  <source>Minerva Stomatol</source>
                  <year>2011</year>
                  <volume>60</volume>
                  <fpage>509</fpage>
                  <lpage>527</lpage>
                  <?supplied-pmid 22082856?>
                  <pub-id pub-id-type="pmid">22082856</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kissin</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Preemptive analgesia</article-title>
                  <source>Anesthesiology</source>
                  <year>2000</year>
                  <volume>93</volume>
                  <fpage>1138</fpage>
                  <lpage>1143</lpage>
                  <pub-id pub-id-type="doi">10.1097/00000542-200010000-00040</pub-id>
                  <pub-id pub-id-type="pmid">11020772</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van Backer</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Jordan</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Leahy</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Moore</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Callas</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Dominick</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Cataldo</surname>
                      <given-names>PA</given-names>
                    </name>
                  </person-group>
                  <article-title>Preemptive analgesia decreases pain following anorectal surgery: a prospective, randomized, double-blinded. Placebo-controlled trial</article-title>
                  <source>Dis Colon Rectum</source>
                  <year>2018</year>
                  <volume>61</volume>
                  <fpage>824</fpage>
                  <lpage>829</lpage>
                  <pub-id pub-id-type="doi">10.1097/DCR.0000000000001069</pub-id>
                  <pub-id pub-id-type="pmid">29771804</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boonriong</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tangtrakulwanich</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Glabglay</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Nimmaanrat</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial</article-title>
                  <source>BMC Musculoskelet Disord</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <fpage>246</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2474-11-246</pub-id>
                  <pub-id pub-id-type="pmid">20973952</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ko-Iam</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Paiboonworachat</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pongchairerks</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Junrungsee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sandhu</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Combination of etoricoxib and low-pressure pneumoperitoneum versus standard treatment for the management of pain after laparoscopic cholecystectomy: a randomized controlled trial</article-title>
                  <source>Surg Endosc</source>
                  <year>2016</year>
                  <volume>30</volume>
                  <fpage>4800</fpage>
                  <lpage>4808</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00464-016-4810-4</pub-id>
                  <pub-id pub-id-type="pmid">26905574</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nascimento</surname>
                      <given-names>VP</given-names>
                    </name>
                    <name>
                      <surname>Primiano</surname>
                      <given-names>HP</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Maia</surname>
                      <given-names>OO</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Pelayes</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Takahashi</surname>
                      <given-names>WY</given-names>
                    </name>
                  </person-group>
                  <article-title>Analgesic effect of etoricoxib (Arcoxia®) 120 mg during retinal laser photocoagulation</article-title>
                  <source>Eur J Ophthalmol</source>
                  <year>2012</year>
                  <volume>22</volume>
                  <fpage>388</fpage>
                  <lpage>392</lpage>
                  <pub-id pub-id-type="doi">10.5301/ejo.5000028</pub-id>
                  <pub-id pub-id-type="pmid">21786271</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lin</surname>
                      <given-names>HY</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>TT</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Lei</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Lac</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gammaitoni</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Smugar</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>WJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial</article-title>
                  <source>Int J Rheum Dis</source>
                  <year>2010</year>
                  <volume>13</volume>
                  <fpage>144</fpage>
                  <lpage>150</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1756-185X.2010.01468.x</pub-id>
                  <pub-id pub-id-type="pmid">20536599</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>WN</given-names>
                    </name>
                    <name>
                      <surname>Tso</surname>
                      <given-names>TK</given-names>
                    </name>
                  </person-group>
                  <article-title>Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly</article-title>
                  <source>Bosn J Basic Med Sci</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>87</fpage>
                  <lpage>94</lpage>
                  <?supplied-pmid 28954205?>
                  <pub-id pub-id-type="pmid">28954205</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gottesdiener</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Schnitzer</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bockow</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Markenson</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ko</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>DeTora</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Geissler</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gertz</surname>
                      <given-names>BJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis</article-title>
                  <source>Rheumatology (Oxford)</source>
                  <year>2002</year>
                  <volume>41</volume>
                  <fpage>1052</fpage>
                  <lpage>1061</lpage>
                  <pub-id pub-id-type="doi">10.1093/rheumatology/41.9.1052</pub-id>
                  <pub-id pub-id-type="pmid">12209041</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Curtis</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Bockow</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Olaleye</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Compton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ko</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Reicin</surname>
                      <given-names>AS</given-names>
                    </name>
                  </person-group>
                  <article-title>Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial NCT00242489</article-title>
                  <source>BMC Musculoskelet Disord</source>
                  <year>2005</year>
                  <volume>6</volume>
                  <fpage>58</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2474-6-58</pub-id>
                  <pub-id pub-id-type="pmid">16321158</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gupta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kandula</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Laxmikanth</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Vyavahare</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Ramachandra</surname>
                      <given-names>CS</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlling pain during orthodontic fixed appliance therapy with non-steroidal anti-inflammatory drugs (NSAID): a randomized, double-blinded, placebo-controlled study</article-title>
                  <source>J Orofac Orthop</source>
                  <year>2014</year>
                  <volume>75</volume>
                  <fpage>471</fpage>
                  <lpage>476</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00056-014-0243-7</pub-id>
                  <pub-id pub-id-type="pmid">25355194</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buvanendran</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kroin</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Berger</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Hallab</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Saha</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Negrescu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Moric</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Caicedo</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Tuman</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans</article-title>
                  <source>Anesthesiology</source>
                  <year>2006</year>
                  <volume>104</volume>
                  <fpage>403</fpage>
                  <lpage>410</lpage>
                  <pub-id pub-id-type="doi">10.1097/00000542-200603000-00005</pub-id>
                  <pub-id pub-id-type="pmid">16508385</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Renner</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Zacher</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Buvanendran</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Walter</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Strauss</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Brune</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery—a pilot study</article-title>
                  <source>Naunyn Schmiedebergs Arch Pharmacol</source>
                  <year>2010</year>
                  <volume>381</volume>
                  <fpage>127</fpage>
                  <lpage>136</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00210-009-0482-0</pub-id>
                  <pub-id pub-id-type="pmid">20052461</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malmstrom</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Fricke</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Shingo</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Reicin</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain</article-title>
                  <source>Curr Med Res Opin</source>
                  <year>2005</year>
                  <volume>21</volume>
                  <fpage>141</fpage>
                  <lpage>149</lpage>
                  <pub-id pub-id-type="doi">10.1185/030079904X17983</pub-id>
                  <pub-id pub-id-type="pmid">15881486</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Agrawal</surname>
                      <given-names>NG</given-names>
                    </name>
                    <name>
                      <surname>Porras</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Matthews</surname>
                      <given-names>CZ</given-names>
                    </name>
                    <name>
                      <surname>Rose</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Woolf</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Musser</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Dynder</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Mazina</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Lasseter</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Hunt</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>JI</given-names>
                    </name>
                    <name>
                      <surname>McCrea</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Gottesdiener</surname>
                      <given-names>KM</given-names>
                    </name>
                  </person-group>
                  <article-title>Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man</article-title>
                  <source>J Clin Pharmacol</source>
                  <year>2003</year>
                  <volume>43</volume>
                  <fpage>268</fpage>
                  <lpage>276</lpage>
                  <pub-id pub-id-type="doi">10.1177/0091270003251122</pub-id>
                  <pub-id pub-id-type="pmid">12638395</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
